Overall, The Cooper Companies, Inc. demonstrates a strong business quality with solid revenue growth, competitive advantages, and operational excellence. Future prospects appear positive with innovative product launches and favorable market trends, although challenges in specific markets like China and potential inventory risks remain. The company is well-positioned for continued growth if they can effectively execute their strategies.
Analysis Date: March 6, 2025 Last Updated: May 29, 2025
+63%
+5.0% per year
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
CountryUS
ExchangeNASDAQ
IndustryMedical - Instruments & Supplies
SectorHealthcare
Market Cap$18.56B
CEOMr. Albert G. White III
The Cooper Companies, Inc. makes products that help people with their vision and health. They have two main parts: CooperVision, which creates contact lenses for people who need help seeing clearly, and CooperSurgical, which provides medical tools and services for women's health and family planning. Basically, they help people see better and support women's health needs around the world. The company started in 1958 and is based in San Ramon, California.
Streams of revenue
Coopervision Segment:66%
Coopersurgical Segment:34%
Geographic Distribution
Europe:55%
UNITED STATES:45%
Core Products
👓
ClaritiDaily lenses
🔍
MiSightMyopia control
⚕️
ParagardIUD contraceptive
💧
ProclearHydrating lenses
👁️
BiofinityMonthly lenses
Business Type
Business to Business
Competitive Advantages
Unlock Competitive Advantages Analysis
Discover all competitive advantages and strategic moats that protect COO's market position.
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Graham Value Metrics
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
📊
Unlock Graham value analysis
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Income Statement Flow
Scroll horizontally to see more
About Profitability Metrics
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
📊
Unlock Profitability Metrics
Access detailed profitability metrics with visual gauges and benchmarks
COO Stock Analysis: The Cooper Companies, Inc. Investment Guide
COO (The Cooper Companies, Inc.) is a Healthcare company listed on NASDAQ Global Select. The stock has generated 5.0% annual returns with an overall investment score of None/100.
Overall, The Cooper Companies, Inc. demonstrates a strong business quality with solid revenue growth, competitive advantages, and operational excellence. Future prospects appear positive with innovative product launches and favorable market trends, although challenges in specific markets like China and potential inventory risks remain. The company is well-positioned for continued growth if they can effectively execute their strategies.
COO Key Financial Metrics
COO financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. The company has a valuation score of 2.5/100 and profitability score of 5.0/100 with financial health rated 7.1499999999999995/100.
About The Cooper Companies, Inc.
The Cooper Companies, Inc. makes products that help people with their vision and health. They have two main parts: CooperVision, which creates contact lenses for people who need help seeing clearly, and CooperSurgical, which provides medical tools and services for women's health and family planning. Basically, they help people see better and support women's health needs around the world. The company started in 1958 and is based in San Ramon, California.
COO Investment Recommendation
Based on our comprehensive analysis of COO, investors should consider the company's positive performance track record, earnings consistency (7/10 quarters beat expectations), and current valuation metrics when making investment decisions.
Healthcare Sector Analysis
COO operates in the Medical - Instruments & Supplies industry within the Healthcare sector. This analysis compares The Cooper Companies, Inc. performance against industry and sector benchmarks to provide context for investment decisions.
Frequently Asked Questions about COO Stock
Is COO a good investment?
COO (The Cooper Companies, Inc.) has generated 5.0% annual returns with an overall score of None/100. Overall, The Cooper Companies, Inc. demonstrates a strong business quality with solid revenue growth, competitive advantages, and operational excellence. Future prospects appear positive with innovative product launches and favorable market … Investors should consider their risk tolerance and investment goals when evaluating COO.
What is COO P/E ratio and valuation?
COO valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Instruments & Supplies industry and Healthcare sector benchmarks. The company currently has a valuation score of 2.5/100.
Should I buy COO stock now?
The decision to buy COO stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 5.0/100, financial health score of 7.1499999999999995/100, and detailed performance metrics to help inform your investment decision.
What are COO financial health indicators?
COO financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 7.1499999999999995/100 based on comprehensive analysis of balance sheet strength and operational efficiency.
How does COO compare to competitors?
COO performance is benchmarked against Medical - Instruments & Supplies industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for The Cooper Companies, Inc.'s market position.
What are COO historical returns?
COO has generated 5.0% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.
COO Key Investment Metrics Summary
Annual Return: 5.0%
Valuation Score: 2.5/100
Profitability Score: 5.0/100
Financial Health Score: 7.1499999999999995/100
Growth Score: 1.5918757323405859/100
Earnings Beat Rate: 7/10 quarters
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: NASDAQ Global Select
Market Cap: 18563214830
COO Investment Thesis
The Cooper Companies, Inc. (COO) represents a conservative investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.
Investment Strengths
Moderate Price-to-Earnings Ratio
Reasonable Price-to-Book Ratio
Strong Gross Profit Margin
Healthy Net Profit Margin
Strong Current and Quick Ratios
Low Debt Levels
Strong Revenue Growth
Competitive Advantages in Product Offerings
Operational Excellence
Innovative Product Pipeline
Positive Market Trends
Focus on Myopia Management
Investment Risks
High Price-to-Cash Flow Ratio
Elevated EV/EBITDA Ratio
Low Return on Equity
Low Cash Ratio
Challenges in Chinese Market
Dependence on Market Execution
We use cookies to analyze site traffic and optimize your site experience.
By accepting, you consent to our use of cookies. Read our Privacy Policy to Learn more.
